Anti-oxPTM-CII scFv was expressed in HB2151 bacteria as described [15 (link)]. ScFv was converted to full length antibody by cloning VH domain into pFUSEss-CHIg-hG1e3 and VL domain into pFUSEss-CLIg-hk (InvivoGen). Plasmid DNA was isolated using a QIAFilter Plasmid Maxi Kit according to the manufacturer’s instruction (QIAGEN). Following transient expression in Expi293F Expression System according to the manufacturer’s instructions (Thermo Fisher Scientific), supernatants were collected and purified using protein A Sepharose CL-4B (GE Healthcare). The ability to retain specific binding of anti-oxPTM-CII over native CII was assessed by ELISA as described [12 (link)].
Free full text: Click here